HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

First detection of Hb Taybe [α38(C3) or α39(C4) Thr→0 (α1)] in an Italian child.

Abstract
Hb Taybe [α38(C3) or α39(C4) Thr→0 (α1)] is an unstable hemoglobin (Hb) variant caused by a deletion of a threonine residue at codon 39 of the α1-globin chain. Usually asymptomatic or with minimal hematological abnormalities in the heterozygous state, Hb Taybe becomes clinically evident in compound heterozygosity with α-thalassemia (α-thal) or in homozygous patients. To date, Hb Taybe has been described in Israeli-Arab and Greek individuals. We report, for the first time, a patient with chronic hemolytic anemia due to the presence of Hb Taybe in trans to the α2 initiation codon mutation ATG>ACG in an Italian child. Hb Taybe was not evident at Hb analysis with cellulose acetate electrophoresis and high performance liquid chromatography (HPLC). Globin biosynthetic studies revealed an α/β-globin ratio in the range of β-thal trait. Consequently, an investigation of the α- and β-globin genes was requested in order to avoid missing any rare globin chain variant and to offer accurate genetic counseling.
AuthorsMaria Elisabetta Paglietti, Maria Carla Sollaino, Daniela Loi, Susanna Barella, Maria Franca Desogus, Renzo Galanello
JournalHemoglobin (Hemoglobin) Vol. 36 Issue 3 Pg. 299-304 ( 2012) ISSN: 1532-432X [Electronic] England
PMID22428534 (Publication Type: Case Reports, Journal Article)
Chemical References
  • Codon, Initiator
  • Hemoglobins, Abnormal
  • alpha-Globins
  • hemoglobin Taybe
  • Threonine
Topics
  • Anemia, Hemolytic (genetics, pathology)
  • Base Sequence
  • Child, Preschool
  • Chronic Disease
  • Codon, Initiator (genetics)
  • DNA Mutational Analysis
  • Hemoglobins, Abnormal (genetics)
  • Humans
  • Italy
  • Male
  • Mutation
  • Sequence Deletion
  • Threonine (genetics)
  • alpha-Globins (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: